LiuSRenJHongZ. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn’s disease: a prospective cohort study. Nutr Clin Pract. 2013;28(1):120-127.
2.
GascheCLomerMCCavillIWeissG. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190-1197.
3.
SpeeckaertMMSpeeckaertRDelangheJR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47(5-6):213-228.
4.
CervelliniISacreSGhezziPMengozziM. Erythropoietin does not affect TNF and IL-6 production directly. J Biol Regul Homeost Agents. 2013;27(1):189-196.
5.
MengRZhuDBiYYangDWangY. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. PLoS One. 2013;8(1):e53557.
6.
YuanRMaedaYLiWLuWCookSDowlingP. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE. PLoS One. 2008;3(4):e1924.
7.
ChenSJWangYLLoWT. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(2):210-223.
